ARTICLE | Company News
Biogen, Berlex musculoskeletal news
October 14, 1996 7:00 AM UTC
A U.S. District Court in Washington, D.C., dismissed a Berlex suit against the FDA. The suit contended that the agency acted improperly in approving BGEN's Avonex interferon beta multiple sclerosis drug (see BioCentury April 29). ...